ʻO Glidiab kahi huakaʻi i noi nui ʻia ma ka lāʻau lapaʻau ka mea e kolohe ana ka hana i ka hoʻomaikaʻi ʻana i ke kūlana o nā mea maʻi me ka maʻi maʻi maʻi type 2. Hiki i nā mea ola o ka hoʻopihapiha ke kōkua i ka hōʻemi o ka glucose o ka glucose a hoʻokumu i ka mana glycemic.
Inoa Kūʻai ʻole honua
INN Gliclazide (gliclazide).
I kā Latin - Glidiab.
Ath
I ka helu ʻana i ka atomic-therapeutic-chemical classization, ua hāʻawi ʻia ka lāʻau lapaʻau i ka code A10BB09.
ʻO Glidiab kahi huakaʻi i noi nui ʻia ma ka lāʻau lapaʻau ka mea e kolohe ana ka hana i ka hoʻomaikaʻi ʻana i ke kūlana o nā mea maʻi me ka maʻi maʻi maʻi type 2.
E hoʻokuʻu i nā palapala a me ka ʻano
Loaʻa ka Glidiab i ke ʻano o nā papa i loaʻa ai kahi ʻano hāmeʻe a me kahi kukala (a i ʻole nā melemele i ʻāpana). Aia ka papa i ka 60 papa.
ʻO ka pahuhopu ikaika i ka pauku me ka gliclazide. ʻO kona kaona i kēlā me kēia papa pālolo ma 80 mg.
ʻO Glidiab MV he 30 mg o ka waiwai ikaika.
ʻO ka hoʻohui pūpū o nā mea i hoʻohui ʻia nā waihona: magnesium stearate, waiū waiū, talc, hypromellose, sodium starch glycolate, MCC.
Loaʻa ka Glidiab i ke ʻano o nā papa i hoʻokaʻawale ʻia ma nā ʻano.
Ka hana lāʻau lapaʻau
ʻO nā papa lāʻau he lāʻau lapaʻau no ka hui o nā aila syntog hypoglycemic. Kuhi ka hopena o ka lāʻau i ka hoʻoponopono ʻana i kekahi mau ʻōnaehana pathological:
- Hoʻomaka nā seleka pancreatic B e hoʻoulu i ka insulin;
- loaʻa nā kōpili peripheral i ka hoʻonui nui ʻana i ka insulin;
- ka hana a ka glucose e loaʻa i ka waiwai i loko o ka ʻikena i loko o ka insulin;
- ka palena mai ka manawa o ka ʻai ʻana a hiki i ka hoʻomaka ʻana o ka hana ʻana i ka insulin;
- hōʻemi ka hoʻonui ʻana o ka postprandial i nā pae o ka glucose;
- ua hoʻihoʻi ʻia ke kakahiaka kiʻekiʻe o nā hana hana.
He hopena maikaʻi ka lāʻau i ka microcirculation:
- hoʻihoʻi ʻia ka hāmeʻa vascular;
- hoʻohui ʻia ke kōpili a me ka adhesion;
- physiological parietal fibrinolysis he maʻamau;
- ka hōʻemi o ka hoʻomohala ʻana i ka atherosclerosis a me ka microthrombosis i hōʻemi ʻia;
- hoʻēmi i ka manaʻo o nā receptors vascular i ka adrenaline.
ʻO ka hoʻohālikelike o kēia lāʻau lapaʻau ka pili pono ana i ka hoʻomaka mua o ka hana huna o ka insulin. Hoʻonohonoho kēia ʻano i nā ala ʻē aʻe, ʻoiai ʻaʻole e hoʻonui nā maʻi i ka paona kino. Kuhi i ka ʻai therapeutic i ʻōlelo ʻia e ke kauka, ʻo kēlā mau maʻi i ke kaumaha e hiki ke hoʻihoʻi i ka paona kino maʻamau.
Lapaʻau lāʻau
Ma hope o ka lawe ʻana i ka lāʻau lapaʻau, ʻoi aku ka nui o ka maʻa o ka hana ikaika i loko o ke kōʻai koko ma hope o 4 mau hola. I loko o nā puʻuwai, e hele mai nā biotransformation o nā metabolites: ua hoʻomehana lākou, aia ka glucuronidation ikaika a me ka hydroxylation. Ma muli o ke kaʻina, ua hoʻokumu ʻia nā metabolites 8 i kūlike ʻole i ka glucose.
Hoʻokuʻu ʻia ka waiwai mai ke kino ma o nā keiki (e pili ana iā 70%) a ma waena o nā ʻāpana (kokoke i 12%). ʻO ka pau hoʻopau hapa-ola e hana ana i nā hola 8-11.
Nā hōʻailona no ka hoʻohana ʻana
Ua kuhikuhi ʻia kēia lāʻau lapaʻau no nā mea maʻi me ka diabetes mellitus type 2 o ka hōʻeha maʻalahi. He kūpono ia i ka wā e kūpaʻa ʻia ai nā paʻakikī (microangiopathy). I kēia mau hihia, hiki ke hoʻohana ʻia ka lāʻau lapaʻau e like me ka monotherapy a i ʻole ka hoʻōla paʻakikī ʻana me ka lāʻau hypoglycemic lāʻau.
Ua kuhikuhi ʻia kēia lāʻau lapaʻau no nā mea maʻi me ka diabetes mellitus type 2 o ka hōʻeha maʻalahi.
E like me ka prophylactic, ʻōlelo ʻia nā papa e pale i ka hoʻomohala ʻana o nā hoʻopiʻi hemorheological i ka maʻi maʻi.
Nā Hoʻohui
ʻO ka papa inoa o nā contraindications i kēia lāʻau lapaʻau e pili ana i nā alaʻala a me nā maʻi.
- maʻi type type 1;
- ka hana hoʻomohala ʻana i ka maʻi type 2;
- ka nui o ke insuloma i ka mea maʻi;
- ketoacidosis;
- renal a me ka nele ole;
- microangiopathy koʻikoʻi;
- maʻi hypersensitivity a sulfonylurea;
- hapai a lactation;
- maʻi lēpela;
- ka manawa o ka hoʻolimalima ʻana o ka hauā ma mua o a ma hope o lākou (48 mau hola);
- keiki malalo o 18 makahiki.
Me ka mālama pono
Wahi a nā ʻōlelo kuhikuhi, aia kekahi mau maʻi a me nā kūlana e pono ai ke koho ʻana i ka lāʻau lapaʻau i ka hoʻoponopono hoʻoponopono ʻana a me ka pinepine o ka hoʻokele. I kēia:
- lipology thyroid;
- fiva
- waiʻawaʻa (waiʻona wai);
- hiki ʻole i ka lula adrenal ikaika;
- ka heleʻana o ka maʻi nephroangiopathy maʻi.
Ma ke alo o kekahi a i ʻole o nā alaka i luna aʻe, pono ke koho i ke kauka i ke ʻano o ka lapaʻau ʻana. Ua noʻonoʻo ʻia ka hiki i ke kuhikuhi ʻana iā Glidiab.
Pehea e lawe ai iā Glidiab
No ka hōʻoluʻolu, he mea maʻamau no ka hoʻokaʻawale ʻana i nā ʻano lā i kēlā me kēia lā i nā lāʻau lapaʻau.
- kūlana - 80 mg / lā .;
- ka awelika - 160 mg / lā .;
- ʻo ka nui he 320 mg / lā.
Hoʻokaʻawale ʻia ka nui o ka laʻe o kēlā me kēia lā i nā ʻāpana like a lawe ʻia i ke kakahiaka a me ke ahiahi 30 mau minuke ma mua o ka papaʻaina. E inu i ka lāʻau lapaʻau me ka wai nui.
Lawe i ka lāʻau lapaʻau no ka maʻi maʻi maʻi
ʻAʻole pono ia e komo i ka lāʻau lapaʻau ponoʻī, ʻoiai ka mea ua pāpā ʻia ka lāʻau no ka diabetes mellitus type 1 a i kēlā me ka 2 no ka hoʻomohala ulu. Ma mua o ka kuhikuhi ʻana i ka pākaukau, e nānā ke kauka i ke ʻano o ka mea maʻi, ka manawa o ka maʻi, nā mākaʻi glycemia, a me ka hiki ʻana o ka lāʻau lapaʻau ʻē aʻe.
Ma mua o ka kuhikuhi ʻana i ka pākaukau, e nānā ke kauka i ke ʻano o ka mea maʻi, ka manawa o ka maʻi, nā mākaʻi glycemia, a me ka hiki ʻana o ka lāʻau lapaʻau ʻē aʻe.
Nā hopena ʻona o Glidaba
Loaʻa nā hopena ʻaoʻao mai ka lawe ʻana i ka lāʻau lapaʻau. I ka nui o nā hihia, ʻae ʻia ʻē aʻe nā papa.
Hoʻopiʻi paha nā maʻi i ka:
- ʻʻAla
- lie kanikela
- luhi;
- nā maʻi kūlohelohe (itching a me urticaria);
- ka hoʻomohala ʻana o kahi maʻi disulfiram-like (ʻeha, ʻeha, a i ʻole constipation);
- asenaiia;
- photosensitization
Ua hōʻike pinepine ʻia:
- paresis;
- hypoglycemia;
- thrombocytopenia;
- agranclocytosis;
- leukopenia;
- anemia
Hoʻopilikia i ka hiki ke mālama i nā mīkini
Ke lawe nei i kēia lāʻau lapaʻau, pono e makaʻala nā mea maʻi e hoʻokele, hana i ka mīkini, a komo i ka haʻuki hoʻokūkū pilikia.
Nā ʻōlelo kikoʻī
No ka hōʻemi i ka hopena o nā hopena hopena, pono ke hōʻiliʻili i ka ʻai. ʻO nā pono nui ka nele o ka pololi a me ka wehe piha ʻana i ka waiʻona.
Hoʻohana ʻia ka papa o ka lāʻau me ke ʻano o kahi meaʻai e waiho ana he liʻiliʻi liʻiliʻi. I kēia hihia, pono ʻoe e kiaʻi mau i ka glucose i loko o ke koko ma kahi ʻōpū ʻole a ma hope o ka ʻai ʻana.
No ka hōʻemi i ka hopena o nā hopena hopena, pono ke hōʻiliʻili i ka ʻai.
I nā hihia a kahi maʻi ke kaumaha a me ke kaumaha paha, e hoʻoponopono ʻia ka nui o ka lāʻau.
Hoʻohana i ka wā hāpai a me ka lactation
ʻAʻole kuhikuhi ʻia ka lāʻau lapaʻau.
Kuhi ʻana iā Glidiab i nā Keiki
Ma muli o ka manaʻo ʻole o ka ʻike i nā mea pōʻino a me nā pono o ka lāʻau lapaʻau no nā keiki, ʻaʻole ia i kuhikuhi no nā poʻe maʻi ma lalo o ka makahiki 18.
Hoʻohana i ka wā kahiko
ʻAʻole pono nā poʻe maʻi kahiko i ka hoʻoponopono hoʻoponopono ʻia. ʻO ka mea ʻē, ʻo ia kēlā mau kānaka i loaʻa i nā ala e pono ai ka makaʻala.
ʻAʻole pono nā poʻe maʻi kahiko i ka hoʻoponopono hoʻoponopono ʻia.
Ka huhū o Glidab
Ke wehe i kēia mau dosapeutic e hoʻonāukiuki i ka nui o ke kō koko. ʻO kēlā mau loli e hiki ke kumu i ka comog hypoglycemic, diabetes precoma.
Hoʻemi ʻia ka stabilization i ka hoʻolauna o ka glucose, sucrose a dextrose paha i loko o ke kino. Nui nā ʻano e hana like ai:
- ʻokoʻa (inā hiki ke mimī kekahi);
- intravenously (inā ʻike ʻole ka mea maʻi) - e hoʻōla ʻia ka hopena o 40 dextrose.
Eia kekahi, ʻoi aku kahi o 1-2 mg o ka momonaagon i ka intramuscularly. Ma hope o ka ʻike hou ʻana o kekahi i ka ʻike, hōʻike ʻia ʻo ia i ka ʻai o nā meaʻai a me nā haʻalulu a maikaʻi ʻole.
Ke wehe i kēia mau dosapeutic e hoʻonāukiuki i ka nui o ke kō koko.
Hoʻopili pū me nā lāʻau ʻē aʻe
I mea e koho ai i kahi kao, pono ke ʻano o ka hoʻohālikelike ʻana i nā lāʻau me nā lāʻau lapaʻau e hoʻohana ʻia ana i ka mālama ʻana.
ʻAʻole kūpono kēia lāʻau lapaʻau i ka hoʻomākaukau ʻana o ka miconazole.
Hoʻohui ʻia ka hana a ka mea hoʻonani gliclazide e nā huaʻōlelo penei:
- nā paʻakau;
- ACE inhibitors;
- beta-blockers;
- ʻike ʻia ʻo Biguanides (metformin);
- anabolic steroid;
- salicylates;
- Nā MAO inhibitors;
- pilikipuna;
- antibiotika
- ka puluʻumeʻuki;
- mau hoa hānau.
Ua hoʻonāwaliwali ka hopena o ka lāʻau e nā lāʻau lapaʻau e hiki mai ana mai ka papa inoa.
- nā glucocorticoids;
- pāpale;
- paeʻāina
- o nā hormone thyroid
- saluretics;
- paʻakai lithium;
- Rifampicin;
- Chlorpromazine;
- Hoʻolau.
ʻO nā dosis kiʻekiʻe o ka estrogen, nā hana hoʻohālikelike waha, hiki ke hoʻohaʻahaʻa i ka hopena nicotinic.
Hoʻolaha ka waipuna
I ka wā mālama me Glidiab, pono e haʻalele iki i ka waiʻona. Ke hoʻohui ʻia me ka haʻahaʻa o ka laʻala. Eia kekahi, ʻo ka hoʻonui ʻia o ka ethanol e piʻi i ka hopena o ka hopena o ka hopena.
Nā kuʻina
ʻO ka lāʻau lapaʻau maoli o kēia hui ʻo Gliclazide (loaʻa iā ia ka waiwai o ka inoa like). ʻO nā lāʻau āpau a pau me kēia ʻano mea ua manaʻo ʻia he mau mea laulā. Ua kapa ʻia nā lāʻau lapaʻau e pili ana i nā hana antidiabetic waha i loaʻa gliclazide:
- Nā maʻi hoʻonaninani;
- Diagnizide;
- Diabefarm;
- Diabinax;
- Predianiana;
- Diabresid;
- Gliklada;
- Diabetalong;
- Kuʻi;
- Predianiana;
- Glioral;
- Diabresid;
- Hula;
- Medoclazide.
Nui nā manaʻo o nā lāʻau lapaʻau e kū like ma ke kumu (type 2 diabetes mellitus). I waena o lākou kekahi o ka poʻe i ʻimi ʻia:
- Januvius;
- Kuʻulaka;
- Bagometua;
- Baeta;
- Lymphomyozot;
- Avandia
- Methamine;
- Kaukaʻikaʻi;
- ʻ Formlelo.
Waihue huaʻōlelo waiho nā huaʻōlelo
Oe ke kuai i keia lāʻau lapaʻau ma loko o ka lāʻauʻaiʻai wale ma ka lapaʻau.
Hōʻikeʻike Glidiab
He loli iki ka uku o ka lāʻau lapaʻau ma luna o ke kumukūʻai kumukūʻai o ka lāʻau lapaʻau. Ma Moscow, ke kumukūʻai ke kumukūʻai mai 120 a 160 rubles.
Oe ke kuai i keia lāʻau lapaʻau ma loko o ka lāʻauʻaiʻai wale ma ka lapaʻau.
Ke waiho nei i nā kūlana no ka lāʻau lapaʻau
Kuhi ʻia ka lāʻau no ka B. Pono e mālama i kahi wahi pōʻeleʻele i nā keiki i kahi wela ʻaʻole eʻoi aʻe o + 25 ° C.
ʻO ka lā kau
ʻO ka lōʻihi ka mālama ʻana he 4 mau makahiki. Ma hope o kēia manawa, pāpā ʻia ka lāʻau lapaʻau.
Mea hana
ʻO ka mea hana hana ʻo ka Lūkini ʻo Akhirin Chemical Farm OJSC. ʻO ka keʻena o ka ʻoihana a me ka hana ʻoihana o ka hui i ka māhele o Moscow, ke kauhale o Staraya Kupavna.
Hōʻikeʻike Glidiab
Irina, 49 makahiki, ʻo Tyumen
Ua ho'āinu wau iā Glidiab i hoʻokahi makahiki i kēia manawa, ua noho mālie koʻu kūlana. Eʻoluʻolu: inu ʻoe i kahi paila i ke kakahiaka a hiki lele ʻoe e hele i ka hana a mai hopohopo i ka kō. ʻO ka mea wale nō e pono e poina ai, he papa lāʻau lapaʻau. Inā ʻaʻole, ʻaʻole aneane hiki ka lāʻau lapaʻau.
Natalia, 35 makahiki, Izhevsk
No kekahi manawa ua inu au i kekahi lāʻau lapaʻau me kahi ʻano like. Ma kahi mau mahina i hala aku nei, ua neʻe ke kauka i Glidiab. I ka wā mua, ua hoʻokala ia i ka hōʻeha ʻole o ka ʻōpū. Ma hope o kekahi mau pule, ua hala ka hopena. Hoʻomau wau e lawe i kēia mau pil. Ma kēia manawa, maikaʻi loa nā mea a pau.
